Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158327 · ClinicalTrials.gov registry record · Phase 3
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
A Phase 3 study of Anxiety Disorders and Panic Disorder, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT00158327 is a Phase 3 study of Anxiety Disorders and Panic Disorder that has completed, run by University of Pittsburgh. The registered enrollment target is 360 participants, below the 1,136-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00158327, a Phase 3 study of Anxiety Disorders and Panic Disorder, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Telephone-based collaborative care
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2004-03 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158327
The ClinicalTrials.gov registry entry for NCT00158327 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,136-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (68% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00158327 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00158327 about?
NCT00158327 is a clinical study titled "Telephone-Based Care Management Program for Individuals With Anxiety Disorders". This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.
What is the current status of trial NCT00158327?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2004-03. Estimated completion is 2011-02.
What conditions does trial NCT00158327 study?
This clinical trial studies the following conditions: Anxiety Disorders, Panic Disorder.
What interventions are being tested in trial NCT00158327?
The interventions under investigation include: Usual care (BEHAVIORAL), Telephone-based collaborative care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00158327?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00158327 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
RECRUITING · Phase 3
-
Fluoxetine vs CBT in Childhood Anxiety Disorders
ACTIVE NOT RECRUITING · Phase 3
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
COMPLETED · Phase 3
-
Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
COMPLETED · Phase 3
-
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 3
-
School-based Treatment for Anxious Children
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.